In addition to pancreatic cancers, IGF2BP3 is highly expressed in various cancers including lung, liver, breast, skin, and colon (Samanta et al. 2013; Zhao et al. 2017; Xu et al. 2019; Hanniford et al. 2020; Huang et al. 2020). Here, IGF2BP3 is linked to pancreatic neoplasm.